Cargando…
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
Ovarian cancer is one of the most lethal malignant tumors in women. The prognosis of ovarian cancer patients depends, in part, on their response to platinum-based chemotherapy. Our recent analysis of genomics and clinical data from the Cancer Genome Atlas demonstrated that somatic mutations of ADAMT...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687615/ https://www.ncbi.nlm.nih.gov/pubmed/29179445 http://dx.doi.org/10.18632/oncotarget.11120 |